Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.22.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 817 $ 760
Accounts receivable and contract assets, net of allowance for credit losses of $29 million and $28 million, respectively 180 142
Income taxes receivable 47 48
Other current assets 32 26
Total current assets 1,076 976
Property and equipment, net 114 118
Intangible assets not subject to amortization:    
Goodwill 2,216 2,220
Trademarks 729 730
Intangible assets not subject to amortization 2,945 2,950
Intangible assets subject to amortization, net 127 133
Other assets, at cost, net of accumulated amortization 192 199
Total assets 4,454 4,376
Current liabilities:    
Deferred merchant and other payables 209 140
Deferred revenue 59 36
Current portion of debt (note 5) 41  
Accrued liabilities and other current liabilities 208 180
Total current liabilities 517 356
Long-term debt, including $272 million and $268 million measured at fair value as of March 31, 2022 and December 31, 2021, respectively (note 5) 1,106 1,143
Deferred income tax liabilities 143 144
Financial instrument liabilities (note 4) 79 85
Series A Preferred Stock liability (note 6) 216 212
Other liabilities 303 309
Total liabilities 2,364 2,249
Equity:    
Additional paid-in capital 284 288
Accumulated other comprehensive earnings (loss), net of taxes (18) (21)
Retained earnings (deficit) (496) (469)
Total stockholders' equity (229) (201)
Noncontrolling interests in equity of subsidiaries 2,319 2,328
Total equity 2,090 2,127
Commitments and contingencies (note 8)
Total liabilities and equity 4,454 4,376
Series A    
Equity:    
Common stock value 1 1
Series B    
Equity:    
Common stock value
Series C    
Equity:    
Common stock value